Richard A. Schnizer

Array ( [id] => 8792848 [patent_doc_number] => 20130109817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'Modified Polymers for Delivery of Polynucleotides, Method of Manufacture, and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/735872 [patent_app_country] => US [patent_app_date] => 2013-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34317 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13735872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10940245 [patent_doc_number] => 20140343266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'ANTISENSE NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 14/368307 [patent_app_country] => US [patent_app_date] => 2012-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 29546 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9857340 [patent_doc_number] => 20150037357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'IMMUNE STIMULATION/METABOLIC INHIBITION AS ANTITUMOR THERAPY' [patent_app_type] => utility [patent_app_number] => 14/368277 [patent_app_country] => US [patent_app_date] => 2012-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2033 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10241585 [patent_doc_number] => 20150126580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'METHODS FOR DIAGNOSING AND TREATING ONCOGENIC KRAS-ASSOCIATED CANCER' [patent_app_type] => utility [patent_app_number] => 14/367341 [patent_app_country] => US [patent_app_date] => 2012-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 30379 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9581728 [patent_doc_number] => 08771728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Stable lipid-comprising drug delivery complexes and methods for their production' [patent_app_type] => utility [patent_app_number] => 13/712804 [patent_app_country] => US [patent_app_date] => 2012-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 17009 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13712804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8891095 [patent_doc_number] => 20130164279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'Micro RNA-148A as a Biomarker for Advanced Colorectal Cancer' [patent_app_type] => utility [patent_app_number] => 13/708537 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12582 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13708537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9857384 [patent_doc_number] => 20150037401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'siRNA Compositions and Methods for Inhibiting Gene Expression in Tumor Initiating Cells of breast Cancer' [patent_app_type] => utility [patent_app_number] => 14/363545 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 23882 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8744614 [patent_doc_number] => 20130084331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'Novel Therapeutic RNA Interference Technology Targeted to the PDX-1 Oncogene in PDX-1 Expressing Neuroendocrine Tumors' [patent_app_type] => utility [patent_app_number] => 13/693578 [patent_app_country] => US [patent_app_date] => 2012-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13254 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13693578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8756160 [patent_doc_number] => 20130090465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS' [patent_app_type] => utility [patent_app_number] => 13/673466 [patent_app_country] => US [patent_app_date] => 2012-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 64492 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13673466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9785672 [patent_doc_number] => 20140302492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'METHOD OF DETECTING AND/OR QUALIFYING AN ANALYTE IN A BIOLOGICAL SAMPLE' [patent_app_type] => utility [patent_app_number] => 14/355765 [patent_app_country] => US [patent_app_date] => 2012-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9121 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8853057 [patent_doc_number] => 20130142728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'MIRNAS AS DIAGNOSTIC BIOMARKERS TO DISTINGUISH BENIGN FROM MALIGNANT THYROID TUMORS' [patent_app_type] => utility [patent_app_number] => 13/662450 [patent_app_country] => US [patent_app_date] => 2012-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 199769 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13662450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8780510 [patent_doc_number] => 20130102485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'Method of Determining a Diseased State in a Subject' [patent_app_type] => utility [patent_app_number] => 13/656201 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10902 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11229835 [patent_doc_number] => 09457046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Compounds for the treatment of ischemic injury' [patent_app_type] => utility [patent_app_number] => 14/351279 [patent_app_country] => US [patent_app_date] => 2012-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 27983 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8768143 [patent_doc_number] => 20130096180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same' [patent_app_type] => utility [patent_app_number] => 13/649654 [patent_app_country] => US [patent_app_date] => 2012-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3149 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13649654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8744544 [patent_doc_number] => 20130084261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/646947 [patent_app_country] => US [patent_app_date] => 2012-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8119 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13646947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638071 [patent_doc_number] => 20130029874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'MICRORNA MARKERS FOR RECURRENCE OF COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/646509 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 27414 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13646509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9686630 [patent_doc_number] => 20140243396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'METHOD OF TREATING MUCOEPIDERMOID CARCINOMA' [patent_app_type] => utility [patent_app_number] => 14/347961 [patent_app_country] => US [patent_app_date] => 2012-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14578 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14347961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662319 [patent_doc_number] => 08809296 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Apoptosis inducer for cancer cell' [patent_app_type] => utility [patent_app_number] => 13/629226 [patent_app_country] => US [patent_app_date] => 2012-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14584 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13629226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884088 [patent_doc_number] => 20130157272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'METHODS AND COMPOSITIONS INVOLVING MIR-135B FOR DISTINGUISHING PANCREATIC CANCER FROM BENIGN PANCREATIC DISEASE' [patent_app_type] => utility [patent_app_number] => 13/615066 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 41354 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13615066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9657238 [patent_doc_number] => 20140228243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'PROGNOSTIC METHODS AND COMPOSITIONS FOR PREDICTING INTERFERON TREATMENT EFICACY IN A SUBJECT' [patent_app_type] => utility [patent_app_number] => 14/342603 [patent_app_country] => US [patent_app_date] => 2012-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 39100 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342603 [rel_patent_id] =>[rel_patent_doc_number] =>)